Action of l-citrulline to prevent or treat endothelial dysfunction
US-2025170084-A1 · May 29, 2025 · US
This page is not indexed by search engines while we improve data quality.
Asklepion Pharmaceuticals Llc patents
Asklepion Pharmaceuticals Llc holds 4 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 4 |
| Recent patents | 3 |
| First publication | Dec 22, 2022 |
| Latest publication | May 29, 2025 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Action of L-citrulline to prevent or treat endothelial dysfunction
US-12064409-B2 · Aug 20, 2024 · US
Therapeutic window for citrulline therapy
US-2023404956-A1 · Dec 21, 2023 · US
Action of l-citrulline to prevent or treat endothelial dysfunction
US-2022401396-A1 · Dec 22, 2022 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Action of l-citrulline to prevent or treat endothelial dysfunction
US-2025170084-A1 · May 29, 2025 · US
Action of L-citrulline to prevent or treat endothelial dysfunction
US-12064409-B2 · Aug 20, 2024 · US
Therapeutic window for citrulline therapy
US-2023404956-A1 · Dec 21, 2023 · US
Action of l-citrulline to prevent or treat endothelial dysfunction
US-2022401396-A1 · Dec 22, 2022 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 4 |